These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 131072)

  • 41. Use of a dynamic rangeshifter for modifying the depth-dose distributions of negative pions.
    Amols HI; Liska DJ; Halbig J
    Med Phys; 1977; 4(5):404-7. PubMed ID: 409920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of a negative pion beam in a therapeutic application.
    Richman C
    Radiology; 1975 Jul; 116(1):187-9. PubMed ID: 806098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The suitability of negative pions for radiotherapy: 4 years preclinical research with the biomedical PiE3-beam at SIN.
    Fritz-Niggli H
    Radiat Environ Biophys; 1979 Aug; 16(3):185-92. PubMed ID: 116302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of a bolus and inhomogeneities on pion stopping distributions.
    Wright HA; Turner JE; Hamm RN
    Med Phys; 1984; 11(6):751-4. PubMed ID: 6439988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiobiological data for clinical dosimetry in pion tumour therapy.
    Heyder IR; Pohlit W
    Radiat Environ Biophys; 1979 Aug; 16(3):251-60. PubMed ID: 116310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current status of clinical pion radiotherapy.
    Kligerman MM; Black WC; Yuhas JM; Doberneck RC; Bradbury JN; Kelsey CA
    Radiology; 1977 Nov; 125(2):489-92. PubMed ID: 910063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomedical program leading to therapeutic trials on pion radiation at Los Alamos.
    Kligerman MM; Knapp EA; Petersen DF
    Cancer; 1975 Nov; 36(5):1675-80. PubMed ID: 1192358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of negative pions, relative to 140 kV -- 29 MeV photons and 20 MeV electrons, on proliferation of Ehrlich ascites carcinoma cells.
    Rao KR; Blattmann H; Cordt I; Fritz-Niggli H
    Radiat Environ Biophys; 1979 Aug; 16(3):261-5. PubMed ID: 574300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preliminary results of a Phase I/II study with pi-meson (pion) treatment for bladder cancer.
    Studer UE; Von Essen CF; Enderli JB; Bodendörfer G; Zingg EJ
    Cancer; 1985 Oct; 56(8):1943-52. PubMed ID: 3928134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pion in vivo dosimetry using aluminum activation.
    Hogstrom KR; Amols HI
    Med Phys; 1980; 7(1):55-60. PubMed ID: 6767905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pions, Vancouver.
    Goodman GB; Douglas BG; Jackson SM; Kornelsen RO; Lam GK; Ludgate CM; Skarsgard LD
    Int J Radiat Oncol Biol Phys; 1982 Dec; 8(12):2187-90. PubMed ID: 6298159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment planning for negative pi-meson radiation therapy: simultaneous multi-port irradiation with the Stanford Medical Pion Generator (SMPG).
    Pistenma DA; Li GC; Fessenden P; White K; Bagshaw MA
    Int J Radiat Oncol Biol Phys; 1977; 3():315-23. PubMed ID: 96067
    [No Abstract]   [Full Text] [Related]  

  • 53. The PIOTRON: initial performance, preparation and experience with pion therapy.
    von Essen CF; Blattmann H; Crawford JF; Fessenden P; Pedroni E; Perret C; Salzmann M; Shortt K; Walder E
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1499-509. PubMed ID: 6815138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rad conversion factor of ionization chamber for high energy x-rays and electrons (author's transl)].
    Antoku S; Sunayashiki T; Takeshita K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1973 Aug; 33(8):683-8. PubMed ID: 4519913
    [No Abstract]   [Full Text] [Related]  

  • 55. Dose outside the treatment volume for irradiation with negative pions.
    Amols HI; Bradbury JN; Dicello JF; Helland JA; Kligerman MM; Lane TF; Paciotti MA; Roeder DL; Schillaci ME
    Phys Med Biol; 1978 May; 23(3):385-96. PubMed ID: 674356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurements at the piE3 single beam correlated to dosimetry and therapy-planning for the pion applicator at SIN.
    Salzmann M
    Radiat Environ Biophys; 1979 Aug; 16(3):219-23. PubMed ID: 116306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy planning and dosimetry for the pion applicator at the Swiss Institute for Nuclear Research (SIN).
    Blattmann H
    Radiat Environ Biophys; 1979 Aug; 16(3):205-9. PubMed ID: 116304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measurement of stopping power ratios for 60 MeV positive or negative pions.
    Nordin JA; Henkelman RM
    Phys Med Biol; 1979 Jul; 24(4):781-92. PubMed ID: 112597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pion treatment procedures and verification techniques.
    Zink SR; Bush SE; Gilman CJ; Hilko RH; Justice RK; Osborne EC; Smith AR; Berardo PA
    Int J Radiat Oncol Biol Phys; 1984 May; 10(5):723-35. PubMed ID: 6429096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Some long-term effects of negative pions in mice exposed to partial body irradiation.
    Coggle JE
    Br J Radiol; 1977 Sep; 50(597):658-62. PubMed ID: 901978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.